Zhuoli Zhang

Title(s)	Professor, Radiological Sciences
School	School of Medicine
Address	1001 Health Sciences Road Irvine CA 92697-3950
Phone	(949) 824-1283, (949) 824-7820
vCard	Download vCard

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Therapy Combining Sorafenib and Natural Killer Cells for Hepatocellular Carcinoma: Insights from Magnetic Resonance Imaging and Histological Analyses. Cancers (Basel). 2025 Feb 19; 17(4). Zhang Z, Yu G, Eresen A, Hou Q, Webster S, Amirrad F, Nauli S, Zhang Z. PMID: 40002292; PMCID: PMC11853247.

View in: PubMed Mentions:
Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells. Cells. 2025 01 22; 14(3). Singer M, Valerin J, Zhang Z, Zhang Z, Dayyani F, Yaghmai V, Choi A, Imagawa D, Abi-Jaoudeh N. PMID: 39936958; PMCID: PMC11817869.

View in: PubMed Mentions: Fields:
Bio Biophysics Cel Cell Biology Mol Molecular Biology
Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment. Cancers (Basel). 2024 Dec 29; 17(1). Singer M, Zhang Z, Dayyani F, Zhang Z, Yaghmai V, Choi A, Valerin J, Imagawa D, Abi-Jaoudeh N. PMID: 39796695; PMCID: PMC11718901.

View in: PubMed Mentions: 2
Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer. Int J Mol Sci. 2024 Nov 09; 25(22). Yu G, Zhang Z, Eresen A, Hou Q, Amirrad F, Webster S, Nauli S, Yaghmai V, Zhang Z. PMID: 39596108; PMCID: PMC11593706.

View in: PubMed Mentions: Fields:
Bio Biochemistry Che Chemistry Mol Molecular Biology
Translation:Humans
Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in liver cancer. BMC Cancer. 2024 Sep 30; 24(1):1215. Eresen A, Zhang Z, Yu G, Hou Q, Chen Z, Yu Z, Yaghmai V, Zhang Z. PMID: 39350084; PMCID: PMC11443676.

View in: PubMed Mentions: 1 Fields:
Neo Neoplasms
Translation:Humans Animals Cells
Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review. Ann Transl Med. 2024 Aug 01; 12(4):77. Zhang Z, Yu G, Eresen A, Chen Z, Yu Z, Yaghmai V, Zhang Z. PMID: 39118942; PMCID: PMC11304422.

View in: PubMed Mentions: 2
MRI monitoring of combined therapy with transcatheter arterial delivery of NK cells and systemic administration of sorafenib for the treatment of HCC. Am J Cancer Res. 2024; 14(5):2216-2227. Zhang Z, Yu G, Eresen A, Hou Q, Yaghmai V, Zhang Z. PMID: 38859849; PMCID: PMC11162671.

View in: PubMed Mentions:
MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma. J Transl Med. 2024 01 19; 22(1):76. Yu G, Zhang Z, Eresen A, Hou Q, Garcia EE, Yu Z, Abi-Jaoudeh N, Yaghmai V, Zhang Z. PMID: 38243292; PMCID: PMC10797785.

View in: PubMed Mentions: 4 Fields:
Med Medicine (General)
Translation:Animals Cells
Sorafenib plus memory like natural killer cell combination therapy in hepatocellular carcinoma. Am J Cancer Res. 2024; 14(1):344-354. Eresen A, Pang Y, Zhang Z, Hou Q, Chen Z, Yu G, Wang Y, Yaghmai V, Zhang Z. PMID: 38323279; PMCID: PMC10839321.

View in: PubMed Mentions: 6
Adverse events of sorafenib in hepatocellular carcinoma treatment. Am J Cancer Res. 2022; 12(6):2770-2782. Pang Y, Eresen A, Zhang Z, Hou Q, Wang Y, Yaghmai V, Zhang Z. PMID: 35812068; PMCID: PMC9251699.

View in: PubMed Mentions: 10
Early Differentiation of Irreversible Electroporation Ablation Regions With Radiomics Features of Conventional MRI. Acad Radiol. 2022 09; 29(9):1378-1386. Eresen A, Sun C, Zhou K, Shangguan J, Wang B, Pan L, Hu S, Ma Q, Yang J, Zhang Z, Yaghmai V. PMID: 34933803; PMCID: PMC10029937.

View in: PubMed Mentions: 4 Fields:
Rad Radiology
Translation:Animals
Strategies to improve sorafenib efficacy during image-guided treatment of hepatocellular carcinoma. Ann Transl Med. 2021 Dec; 9(23):1745. Eresen A, Zhang Z, Yaghmai V. PMID: 35071439; PMCID: PMC8743717.

View in: PubMed Mentions: 4